Additional studies in mouse models of CRC with RKO cells having TFAM truncation mutations showed that forcibly upregulating the expression of TFAM protein in these cells leads to a significant secretion of cytochrome b (Cyt b) and a higher sensitivity to apoptosis induced by chemotherapy drugs (such as cisplatin). This evidence concerns the gene TFAM and colorectal carcinoma.